INTERNATIONAL PATENT: HANX BIOPHARMACEUTICALS (WUHAN) CO., LTD. FILES APPLICATION FOR "ANTIBODIES TARGETING VEGF AND PD-1/PD-L1 AND USES THEREOF"

GENEVA, April 5 -- HANX BIOPHARMACEUTICALS (WUHAN) CO., LTD. (Building A8, BioPark IIJiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073) filed a patent application (PCT/CN2025/125305) for "ANTIBODIES TARGETING VEGF AND PD-1/PD-L1 AND USES THEREOF" on Sep 29, 2025. With publication no. WO/2026/067774, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KE, Hang (Building A8, BioPark IIJiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073), LI, Jialin (Building A8, BioPark IIJiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430...